Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.
暂无分享,去创建一个
E. Antman | E. Braunwald | P. Stone | J. Muller | E Braunwald | J E Muller | E M Antman | P H Stone | J. Muller
[1] K. Landmark,et al. The effect of nifedipine on the sinus and atrioventricular node of the dog heart after beta-adrenergic receptor blockade. , 2009, British journal of clinical practice. Supplement.
[2] W. Nayler,et al. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. , 1980, The American journal of cardiology.
[3] E. Antman,et al. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. , 1980, The New England journal of medicine.
[4] M. Olivari,et al. Short‐ and Long‐term Efficacy of a Calcium‐antagonistic Agent (Nifedipine) Combined with Methyldopa in the Treatment of Severe Hypertension , 1980, Circulation.
[5] L. Tavazzi,et al. Treatment of angina at rest with nifedipine: a short-term controlled study. , 1980, The American journal of cardiology.
[6] V. Subramanian,et al. VERAPAMIL IN CHRONIC STABLE ANGINA A Controlled Study with Computerised Multistage Treadmill Exercise , 1980, The Lancet.
[7] R. Kloner,et al. Reduction of experimental myocardial infarction size by ORTHO-IODO sodium benzoate , 1980 .
[8] D. Baim,et al. Efficacy of diltiazem in variant angina , 1980 .
[9] D. Mathey,et al. Effect of verapamil on left ventricular relaxation and filling in hypertrophic cardiomyopathy , 1980 .
[10] E. Braunwald,et al. Autoradiography with 99Tc labeled albumin microspheres, a new method for delineation of ischemic tissue at risk of infarction: Demonstration of the protective effect of verapamil , 1980 .
[11] R. Chahine,et al. The effectiveness of combined verapamil and nitrate therapy in Prinzmetal's variant angina , 1980 .
[12] B. Armstrong,et al. Use of carotid artery flow (CAF) patterns as assessed by doppler ultrasonography for the noninvasive evaluation of blalock-taussig shunt (BTS) patency , 1980 .
[13] P. Stein,et al. Distribution of pressure across the left ventricular wall in the beating and arrested heart: Evidence of epicardial muscle tone during diastole , 1980 .
[14] R. Helfant,et al. Abstract of papers to be Presented at the 29th Annual Scientific Session of the American College of Cardiology Houston, Texas, March 9 to 13, 1980The effects of nifedipine on ischemic myocardium: preservation of contraction during partial coronary occlusion , 1980 .
[15] M. Bourassa,et al. Systemic and coronary hemodynamic effects of intravenous diltiazem in patients with coronary artery disease , 1980 .
[16] R. Helfant,et al. Efficacy of nifedipine in the intermediate syndrome refractory to propranolol and nitrate therapy , 1980 .
[17] W. Bussmann,et al. Treatment of hypertrophic obstructive cardiomyopathy with verapamil , 1980, British heart journal.
[18] H. Yasue,et al. Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. , 1979, British journal of clinical practice. Supplement.
[19] M. Endo,et al. Prinzmetal's Variant Form of Angina Pectoris: Re‐evaluation of Mechanisms , 1975, British journal of clinical practice. Supplement.
[20] H. Kishida. Application of Calcium Antagonists in Patients with Prinzmetal Angina Pectoris , 1980 .
[21] M. A. Matlib,et al. Effects of diltiazem, a calcium antagonist, on regional myocardial function and mitochondria after brief coronary occlusion. , 1980, Journal of molecular and cellular cardiology.
[22] B. Maron,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. , 1979, Circulation.
[23] B. Maron,et al. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. , 1979, Circulation.
[24] F. Heupler,et al. Nifedipine therapy for refractory coronary arterial spasm. , 1979, The American journal of cardiology.
[25] D. Hathaway,et al. Role of calcium and cyclic adenosine 3':5' monophosphate in regulating smooth muscle contraction. Mechanisms of excitation-contraction coupling in smooth muscle. , 1979, The American journal of cardiology.
[26] R. E. Clark,et al. Nifedipine: a myocardial protective agent. , 1979, The American journal of cardiology.
[27] M. Kaltenbach,et al. Effects of nifedipine after intravenous and intracoronary administration. , 1979, The American journal of cardiology.
[28] J. Muller,et al. Inappropriate coronary vasoconstriction in patients with coronary artery disease: a role for nifedipine? , 1979, The American journal of cardiology.
[29] R. Zelis,et al. Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. , 1979, The American journal of cardiology.
[30] J. Kastor,et al. Nifedipine in the treatment of Prinzmetal's (variant) angina. , 1979, The American journal of cardiology.
[31] S. Chierchia,et al. Significance of spasm in the pathogenesis of ischemic heart disease. , 1979, The American journal of cardiology.
[32] R. E. Clark,et al. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. , 1979, The American journal of cardiology.
[33] D. Waters,et al. Provocative Testing with Ergonovine to Evaluate the Efficacy of Treatment with Calcium Antagonists in Variant Angina , 1979, Circulation.
[34] Michael V. Green,et al. Effect of Septal Myotomy and Myectomy on Left Ventricular Systolic Function at Rest and During Exercise in Patients with IHSS , 1979, Circulation.
[35] D. C. Brewster,et al. Femoral Artery Pressure Measurement During Aortography , 1979, Circulation.
[36] V. Gott,et al. Comparison of Myocardial Protection with Nifedipine and Potassium , 1979, Circulation.
[37] L. Wexler,et al. Long-term Serial Angiographic Studies After Coronary Artery Bypass Surgery , 1979, Circulation.
[38] R. Bing,et al. Effect of diltiazem, a calcium antagonist, on myocardial ischemia. , 1979, The American journal of cardiology.
[39] L. Ekelund,et al. Antianginal efficiency of nifedipine with and without a beta‐blocker, studied with exercise test. A double‐blind, randomized subacute study , 1979, Clinical cardiology.
[40] M. Olivari,et al. Treatment of Hypertension with Nifedipine, A Calcium Antagonistic Agent , 1979, Circulation.
[41] Kenmure Ac,et al. A double-blind controlled trial of the anti-anginal efficacy of nifedipine compared with propranolol. , 1979, British journal of clinical practice. Supplement.
[42] R. Berne,et al. Differential Effects of Adenosine and Nitroglycerin on the Action Potentials of Large and Small Coronary Arteries , 1979, Circulation research.
[43] W. Aronow,et al. Effects of verapamil on myocardial performance in coronary disease. , 1979, Circulation.
[44] A. Maseri,et al. Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. , 1979, British heart journal.
[45] K. Fox,et al. The Effects of Nifedipine on Acute Experimental Myocardial Ischemia and Infarction in Dogs , 1979, Circulation research.
[46] M. Entman,et al. Elective Ischemic Arrest - New Method of Myocardial Preservation and Subcellular Correlate , 1979 .
[47] E. Grenadier,et al. Nifedipine and Prinzmetal's angina. , 1979 .
[48] M. Hiwatari,et al. Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs. , 1979, Arzneimittel-Forschung.
[49] A. Fabiato,et al. Calcium and cardiac excitation-contraction coupling. , 1979, Annual review of physiology.
[50] K. Landmark,et al. Verapamil and pulmonary hypertension. , 2009, Acta medica Scandinavica.
[51] S. Nitter‐Hauge,et al. Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease. , 2009, Acta medica Scandinavica.
[52] C. Klee,et al. Phosphorylation of smooth muscle myosin light chain kinase by the catalytic subunit of adenosine 3': 5'-monophosphate-dependent protein kinase. , 1978, The Journal of biological chemistry.
[53] Yushi Ito,et al. THE EFFECTS OF DILTIAZEM (CRD‐401) ON THE MEMBRANE AND MECHANICAL PROPERTIES OF VASCULAR SMOOTH MUSCLES OF THE RABBIT , 1978, British journal of pharmacology.
[54] M. Mir,et al. Assessment of perhexiline maleate in angiographically proven intractable angina: A double-blind trial , 1978 .
[55] T. Yoshida,et al. Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade. , 1978, American heart journal.
[56] H. Yasue,et al. Coronary Arterial Spasm and Prinzmetal's Variant Form of Angina Induced by Hyperventilation and Tris-buffer Infusion , 1978, Circulation.
[57] R. Kusukawa,et al. Effects of diltiazem hydrochloride on renal hemodynamics and urinary electrolyte excretion. , 1978, Japanese circulation journal.
[58] C. Rodger,et al. Side effects of nifedipine. , 1978, British medical journal.
[59] V. Bhargava,et al. Electrophysiologic and Hemodynamic Effects of Verapamil: Correlation with Plasma Drug Concentrations , 1978, Circulation.
[60] J. Muller,et al. Nifedipine Therapy for Prinzmetal's Angina , 1978, Circulation.
[61] M. Matsushima,et al. Effects of diltiazem Hydrochloride (CRD-401) on renal hemodynamics of dogs. , 1978, Arzneimittel-Forschung.
[62] T. Morifuji,et al. Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics. , 1978, Arzneimittel-Forschung.
[63] F. Magrini,et al. Nifedipine, a new antihypertensive with rapid action , 1977, Clinical pharmacology and therapeutics.
[64] Bramahn . Singh,et al. Effects of intravenous verapamil on hemodynamics in patients with heart disease. , 1977, American heart journal.
[65] K. Kohno,et al. Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog. , 1977, Arzneimittel-Forschung.
[66] L. Horwitz,et al. Effect of verapamil on left ventricular performance in conscious dogs. , 1977, The Journal of pharmacology and experimental therapeutics.
[67] J. Small,et al. Ca-regulation of mammalian smooth muscle actomyosin via a kinase-phosphatase-dependent phosphorylation and dephosphorylation of the 20 000-Mr light chain of myosin. , 1977, European journal of biochemistry.
[68] G. Mcdonald. LIVER DAMAGE AFTER PERHEXILINE MALEATE , 1977, The Lancet.
[69] M. Blaustein. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. , 1977, The American journal of physiology.
[70] B. Sobel,et al. Lack of protection of ischemic myocardium by verapamil in conscious dogs. , 1977, European journal of pharmacology.
[71] A. Maseri,et al. CORONARY VASOSPASM IN ANGINA PECTORIS , 1977, The Lancet.
[72] J. Lowe,et al. Effect of the Calcium Antagonist Verapamil on Necrosis following Temporary Coronary Artery Occlusion in Dogs , 1977, Circulation.
[73] S. Persson,et al. Double-blind comparison of verapamil and practolol in the treatment of angina pectoris. , 1977, Postgraduate medical journal.
[74] R. M. Mills,et al. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. , 1976, The New England journal of medicine.
[75] J. Griffith,et al. Regional Contractility: Selective Depression of Ischemic Myocardium by Verapamil , 1976, Circulation.
[76] M. Eichelbaum,et al. Physiological disposition of verapamil in man. , 1976, Cardiovascular research.
[77] A. Moir,et al. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart , 1976, Nature.
[78] A. Maseri,et al. Transient Transmural Reduction of Myocardial Blood Flow, Demonstrated by Thallium‐201 Scintigraphy, as a Cause of Variant Angina , 1976, Circulation.
[79] T. Yoshida,et al. Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients. , 1976, Japanese heart journal.
[80] E. Daniel,et al. Calcium Accumulation and Enzymatic Activities of Subcellular Fractions from Aortas and Ventricles of Genetically Hypertensive Rats , 1976, Circulation research.
[81] A. Pichard,et al. Coronary arterial spasm in Prinzmetal's angina: a proved hypothesis. , 1976, The American journal of cardiology.
[82] V. Balasubramanian,et al. Verapamil in ischaemic heart disease—quantitative assessment by serial multistage treadmill exercise , 1976, Postgraduate medical journal.
[83] M. Schlepper,et al. The pharmacodynamics of orally taken verapamil and verapamil retard as judged by their negative dromotropic effects. , 1975, Arzneimittel-Forschung.
[84] B. Singh,et al. Effects of verapamil on infarct size following experimental coronary occlusion. , 1975, Cardiovascular research.
[85] W. Gaasch,et al. Prinzmetal's variant angina: hemodynamic and angiographic observations during pain. , 1975, The American journal of cardiology.
[86] G. Burrows,et al. Intracardiac conduction defects following overdose of tricyclic antidepressant drugs. , 1975, European journal of cardiology.
[87] Norris Rm,et al. Reduction in infarct size following experimental coronary occlusion by administration of verapamil. , 1975 .
[88] Studies on the Extracardial Effects of Nifedipine in Anesthetized Dogs , 1975 .
[89] B. Lewis,et al. Immediate haemodynamic effects of verapamil in man. , 1975, Cardiology.
[90] S. J. Schang,et al. Effects of perhexiline on symptomatic and hemodynamic responses to exercise in patients with angina pectoris. , 1974, The American journal of cardiology.
[91] S. Greenberg,et al. Iproveratril: a nonspecific antagonist of peripheral vascular reactivity. , 1974, Canadian journal of physiology and pharmacology.
[92] S. White,et al. CORONARY HAEMODYNAMIC EFFECTS OF NIFEDIPINE (BAY A 1040) AND GLYCERYL TRINITRATE IN UNANAESTHETIZED DOGS , 1974, Clinical and experimental pharmacology & physiology.
[93] D. E. Potts,et al. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. , 1973, The New England journal of medicine.
[94] G. Langer. Heart: excitation-contraction coupling. , 1973, Annual review of physiology.
[95] T. Whitsett,et al. Proceedings: A controlled study of the diuretic and natriuretic properties of perhexiline maleate in normal human volunteers. , 1973, Postgraduate medical journal.
[96] H. Sacks,et al. Verapamil in cardiac arrhythmias. , 1972, British medical journal.
[97] R. Jennings,et al. Myocardial calcium and magnesium in acute ischemic injury. , 1972, The American journal of pathology.
[98] M. Benaim. Asystole after verapamil. , 1972, British medical journal.
[99] S. Hirakawa,et al. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040. , 1972, Arzneimittel-Forschung.
[100] T. Nagao,et al. Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions. , 1972, Japanese journal of pharmacology.
[101] H. Saller,et al. [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)]. , 1972, Arzneimittel-Forschung.
[102] N. Taira,et al. Cardiohemodynamic effects of BAY a 1040 in the dog. , 1972, Arzneimittel-Forschung.
[103] G. Rowe,et al. The systemic and coronary hemodynamic effects of iproveratril. , 1971, Archives internationales de pharmacodynamie et de therapie.
[104] Hiroyasu Ito,et al. BASIC AND CLINICAL STUDIES ON BAY A 1040 WITH SPECIAL REFERENCE TO ITS INFLUENCE ON THE CORONARY, SYSTEMIC RESISTANCE AND CAPACITANCE BLOOD VESSELS , 1971 .
[105] D. M. Aviado,et al. Pharmacology of a new antianginal drug: perhexiline. I. Coronary circulation and myocardial metabolism. , 1970, Chest.
[106] W. Huber,et al. Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil , 1970 .
[107] A. Katz,et al. Contractile proteins of the heart. , 1970, Physiological reviews.
[108] G. Sandler,et al. Clinical Evaluation of Verapamil in Angina Pectoris , 1968, British medical journal.
[109] D. Phear. Verapamil in angina: a double-blind trial. , 1968, British medical journal.
[110] G. Ross,et al. Cardiovascular actions of iproveratril. , 1967, The Journal of pharmacology and experimental therapeutics.
[111] A. Luisada,et al. DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORIS , 1966, The American journal of the medical sciences.
[112] K. I. Melville,et al. CORONARY VASODILATORY AND CARDIAC ADRENERGIC BLOCKING EFFECTS OF IPROVERATRIL. , 1965, Canadian journal of physiology and pharmacology.
[113] S Ringer,et al. A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart , 1883, The Journal of physiology.